Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03858621
Other study ID # 180522017
Secondary ID FONDECYT Iniciac
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2019
Est. completion date February 23, 2022

Study information

Verified date March 2022
Source Pontificia Universidad Catolica de Chile
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pain is defined as an unpleasant sensory and emotional conscious experience, associated with actual or potential tissue damage. Nociception is the sympathetic response to noxious stimuli during unconsciousness. The appearance of different forms of chronic pain results from sensitization of both peripheral and central neural circuits of pain, which involves inflammatory mechanisms both at a systemic level and specifically in the peripheric and central nervous system, as observed through elevation of specific neuroinflammatory mediators, such as MCP-1, IL-1, IL-1b, and IL-10. Clinically, this sensitization expresses as hyperalgesia and allodynia, which increase postoperative pain and morbidity, but also induce permanent modifications in the nociceptive system. These effects may be ameliorated by adequately adjusting intraoperative analgesia through use of nociception/analgesia balance monitors, of which Nociception Level Index (NOL) shows convenient characteristics and promising results from previous studies. Objectives: The goal of our study is to assess the utility of NOL index monitoring against standard care for Fentanyl-based analgesia by measuring postoperative pain, sensorial thresholds and inflammatory markers related to nociception. Hypothesis: The use of NOL index to guide the intraoperative analgesia will produce less postoperative pain, hyperalgesia, allodynia, and neuroinflammation.


Description:

Methodology: In this RCT double-blinded study will invite to 100 patients aged between 18 and 50 years admitted for elective surgery that is planned to require general anesthesia, with fentanyl as the opioid of choice for intraoperative analgesia. Each patient will be randomly allocated to one of two groups: the intervention group will be provided intraoperative analgesia guided by NOL values (n=50), and the control group will be provided standard intraoperative analgesia (n=50). To account for inter-personal variability, the NOL threshold value associated with nociceptive stimulation will be assessed on each patient at baseline condition with the Quantitative Sensory Testing (QST) and neuroinflammatory mediators MCP-1, IL-1, IL-1b, and IL-10 will be measured pre- and post-surgery in both groups. Opioid consumption and AVS will be assessed during the stay at the post-surgical care unit as a measurement of post-operative pain and will follow them until three months after surgery. Statistical Analysis: Results will be expressed as means (±SD) or numbers (%). When indicated, 95% confidence interval (CI) will be calculated. A p-value < 0.05 will be considered statistically significant. Differences between groups on post-surgical opioid consumption, Δz-score of QST measurements, and serum biomarkers level will be analyzed with Student's T-test for unpaired samples. For analysis purposes, VAS scores will be grouped into three distinct categories: Mild (0-3), Moderate (4-6) and Severe (7-10) pain. Differences between groups will be analyzed with Chi-square test.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date February 23, 2022
Est. primary completion date February 23, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - ASA I-II - Elective abdominal surgery without a neuraxial block. - Over 2 horas. - Body Mass Index 18 - 30 kg/m2 Exclusion Criteria: - Cardiac surgery - Cardiopathy - Arrhythmia or use of pacemakers. - Chronic Kidney disease (Plasma Crea >1 mg/dL). - Allergic to drugs of this study. - Opioids or Non-inflammatory drugs over 5 days for two weeks before surgery. - Neuropathies and dysautonomias. - Beta-blockers and other drugs that act at the level of the sympathetic system the month prior to surgery. - Chemotherapy.

Study Design


Intervention

Drug:
fentanyl NOL guided
Intervention is NOL monitoring in this group that will help to guide intravenous administration of fentanyl during surgery.

Locations

Country Name City State
Chile Victor Contreras Santiago Región Metropolitana

Sponsors (1)

Lead Sponsor Collaborator
Victor Contreras, MSN

Country where clinical trial is conducted

Chile, 

References & Publications (4)

Argoff CE. Recent management advances in acute postoperative pain. Pain Pract. 2014 Jun;14(5):477-87. doi: 10.1111/papr.12108. Epub 2013 Aug 15. Review. — View Citation

Baliki MN, Apkarian AV. Nociception, Pain, Negative Moods, and Behavior Selection. Neuron. 2015 Aug 5;87(3):474-91. doi: 10.1016/j.neuron.2015.06.005. Review. — View Citation

Gandhi K, Heitz JW, Viscusi ER. Challenges in acute pain management. Anesthesiol Clin. 2011 Jun;29(2):291-309. doi: 10.1016/j.anclin.2011.04.009. Review. — View Citation

Katz J, Seltzer Z. Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother. 2009 May;9(5):723-44. doi: 10.1586/ern.09.20. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Consumption of IV fentanyl intra-operative in the NOL-guided group compared to the standard group. Total consumption of fentanyl in mcg. Intra-operative
Primary Consumption of opioid in the early postoperative in the NOL-guided group compared to the standard group. Total consumption of morphine in mg. Postoperative Unit (2 hours)
Secondary Pain measured by Visual Analog Scale (VAS) in the NOL-guided group compared to the standard group. Visual Analog Scale 0 to 10. 0 = no pain. 10 = worse pain Values to find out is less than 5-6 Postoperative Unit (Every 30 minutes per 2 hours)
Secondary Sensorial thresholds in the NOL-guided group compared to the standard group. QST (Quantitative Sensory Testing) is a valuable method for diagnosing peripheral nervous system disorders.
Thermal Testing
Mechanical test threshold
Mechanical pain threshold
Wind-up phenomenon
Vibration detection threshold
Pressure pain threshold
Postoperative Unit (2 hours)
Secondary Pain Management Satisfaction in the NOL-guided group compared to the standard group. Pain Management Satisfaction Scale
1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Postoperative Unit (2 hours)
Secondary Pain Management Satisfaction in the NOL-guided group compared to the standard group. Pain Management Satisfaction Scale
1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Postoperative (6 hours)
Secondary Pain Management Satisfaction in the NOL-guided group compared to the standard group. Pain Management Satisfaction Scale
1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Postoperative (12 hours)
Secondary Inflammatory markers in the NOL-guided group compared to the standard group. Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL) Postoperative (0 hours)
Secondary Inflammatory markers in the NOL-guided group compared to the standard group. Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL) Postoperative (6 hours)
Secondary Inflammatory markers in the NOL-guided group compared to the standard group. Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL) Postoperative (12 hours)
Secondary Persistent pain at three months in the NOL-guided group compared to the standard group. Brief Pain Inventory by telephone call 3 months after surgery
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Recruiting NCT06007378 - Optimizing Postoperative Pain Control After Laparoscopic Colorectal Surgery N/A
Recruiting NCT05943015 - Analgesic Efficacy of Quadratus Lumborum, Paravertebral Blocks N/A
Completed NCT04544228 - Ketamine or Neostigmine for Serratus Anterior Plane Block in Modified Radical Mastectomy N/A
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03663478 - Continuous TQL Block for Elective Cesarean Section Phase 4
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Completed NCT05170477 - Influence of Apical Patency Concept Upon Postoperative Pain After Root Canal Treatment N/A
Not yet recruiting NCT04561856 - Fascia Iliaca Block Supplemented With Perineural Vs Intravenous Dexamethasone Phase 4
Completed NCT06425601 - A Comparison of Silicone Versus Polyvinylchloride (PVC) Drains Following VATS Lobectomy N/A
Completed NCT03612947 - TAP Block in Laparoscopic Cholecystectomy. Phase 2
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Active, not recruiting NCT04190355 - The Effect of Irrigant Types Used During Endodontic Treatment on Postoperative Pain N/A
Recruiting NCT05145153 - Incidence of Chronic Pain After Thoracic Surgery
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A